Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while obinutuzumab/venetoclax does not significantly alter blood viscosity.

Their prevalence and relatively long lifespan are in part why red blood cells are such an attractive target for scientists. Part of the challenge, Mitragotri said, would be ensuring cells aren't ...

Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

Red blood cells provide your body with oxygen from the ... Because many chemotherapy treatments target rapidly dividing cells, hair loss is a common side effect of treatment.

DARPA wants to know if modifying red blood cells can help warfighters "operate more effectively in dangerous or extreme environments." ...

Eating foods high in key nutrients, including iron, folic acid, and vitamin B12, and limiting alcohol may help increase your red blood cell count. Red blood cells are the most common cells in ...

Objective Neural tube defects (NTDs) are a preventable folate deficiency disorder; increasing folic acid intake through food ...

In 2019, the first CRISPR clinical trials were conducted to treat sickle cell diseases and in 2020, this treatment was ...

Plasma is the liquid part of your blood. It’s made of water, proteins, clotting factors, hormones, and other substances. Floating in the plasma are many red blood cells (RBCs). These cells contain ...

Nonetheless, recent evidence suggests that CCR7 is more than a facilitator of lymphatic spread of tumor cells. Here, we review published data to catalogue CCR7 expression across blood cancers and ...

This finding advances our understanding of how blood vessels sprout new branches through cell migration. Blood vessels supply the cells in our bodies with the oxygen and nutrients they need to ...